Over the next few years, the enhancement of immunotherapy efficacy through inhibiting LSD1 was also demonstrated in several other tumors.529–531 The mechanisms of LSD1 ablation in tumor immunity have not been clearly elucidated. This evidence concerns the gene KDM1A and neoplasm.